Stock Events

Stock Events

Sharp Therapeutics 

C$1.3700
0
+C$0.46+50.55%Tuesday 18:23

Statistics

Day High
1.37
Day Low
1.37
52W High
5
52W Low
0.91
Volume
200
Avg. Volume
47
Mkt Cap
41.2M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2022
2023
2024
2025
0Revenue
-8.72MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Sharp Therapeutics Corp., a preclinical-stage drug discovery company, develops therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies that allows the creation of sensitive assays mimicking the genetic disease state, enabling discovery of compounds that correct the mutational defect; AlloChem, a compound library which binds proteins allosterically; and Mine, a custom-built, cloud-distributed analytics platform that captures data for AlloChem compounds in CoreX assays. Sharp Therapeutics Corp. is headquartered in Pittsburgh, Pennsylvania.
Show More
CEO
Dr. Scott F. Sneddon J.D., Ph.D.
Country
Canada
ISIN
CA8200092077

Listings

OTC Link
US
SHRXF
V
CA
SHRX.V
V
CA
EVP-P.V

0 Comments

Share your thoughts

FAQs

What is Sharp Therapeutics stock price today?▼
The current price of SHRX.V is C$1.37 CAD — it has increased by +50.55% in the past 24 hours. Watch Sharp Therapeutics stock price performance more closely on the chart.
What is Sharp Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on TSX Venture Exchange exchange Sharp Therapeutics stocks are traded under the ticker SHRX.V.
Is Sharp Therapeutics stock price growing?▼
SHRX.V stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Sharp Therapeutics has showed a -59.94% decrease.
What is Sharp Therapeutics market cap?▼
Today Sharp Therapeutics has the market capitalization of 41.2M
What is Sharp Therapeutics revenue for the last year?▼
Sharp Therapeutics revenue for the last year amounts to 0 CAD.
What is Sharp Therapeutics net income for the last year?▼
SHRX.V net income for the last year is -8.72M CAD.
In which sector is Sharp Therapeutics located?▼
Sharp Therapeutics operates in the Other sector.
When did Sharp Therapeutics complete a stock split?▼
The last stock split for Sharp Therapeutics was on January 27, 2025 with a ratio of 1:10.
Where is Sharp Therapeutics headquartered?▼
Sharp Therapeutics is headquartered in Pittsburgh, Canada.